Teva CEO Talks Drug Pricing, Generics, Supply Shortages
Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.
You May Also Like
HOGENT: kwaliteit dus!
The Podcast Planet
CFO Podcast
Peter De Roeck
Datasets
Visionary
Proactive - Interviews for investors
Proactive
Mining Stock Daily
Trevor Hall
Earn Your Leisure
iHeartPodcasts
Marketplace Morning Report
Marketplace
Marketplace All-in-One
Marketplace
The Property Academy Podcast
Opes Partners
The Lucy Ann Lance Show
Cumulus Media Detroit
HOGENT: kwaliteit dus!
The Podcast Planet
CFO Podcast
Peter De Roeck
Datasets
Visionary
Proactive - Interviews for investors
Proactive
Mining Stock Daily
Trevor Hall
Earn Your Leisure
iHeartPodcasts
Marketplace Morning Report
Marketplace
Marketplace All-in-One
Marketplace
The Property Academy Podcast
Opes Partners
The Lucy Ann Lance Show
Cumulus Media Detroit
Community discussion